Prevention of cardiovascular disease

References

• Vlietstra RE, Frye RL, Kronmal RA, et al. Risk factors and angiographic coronary artery disease: a report from the Coronary Artery Surgery Study (CASS). Circulation 1980: 62(2): 254–61
   PubMed Web of Science ®Google Scholar
• Vlietstra RE, Kronmal RA, Frye RL, et al. Factors affecting the extent and severity of coronary artery disease In patients enrolled in the Coronary Artery Surgery Study. Arteriosclerosis 1982: 2(3): 208–15
   PubMedGoogle Scholar
• Hopkins PN, Williams RR. Identification and relative weight of cardiovascular risk factors. Cardiol Clin 1986: 4(1): 3–31
   PubMedGoogle Scholar
• Jain AK. Cigarette smoking, use of oral contraceptives. and myocardial Infarction. Am J Obstet Gynecol 1976: 126(3): 301–7
   PubMed Web of Science ®Google Scholar
• Garland C, Barrett-Connor E, Suarez L, et al. Effects of passive smoking on ischemic heart disease mortality of nonsmokers: a prospective study. Am J Epidemiol 1985: 121 (5): 645–50
   PubMed Web of Science ®Google Scholar
• Gordon T, Kannel WB. McGee D, et al. Death and coronary attacks in men after giving up cigarette smoking: a report from the Framingham study. Lancet 1974: 2(7893): 1345–8
   PubMed Web of Science ®Google Scholar
• Aberg A, Bergstrand R, Johansson S. et al. Cessation of smoking after myocardial infarction: effects on mortality after 10 years. Br Heart J 1983: 49(5): 416–22
   PubMedGoogle Scholar
• Rosenberg L, Kaufman DW, Helmrich SP, et al. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985: 313(24): 1511–4
   PubMed Web of Science ®Google Scholar
• Vlietstra RE, Kronmal RA, Oberman A, et al. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease: report from the CASS registry. JAMA 1986: 255(8): 1023–7
   PubMed Web of Science ®Google Scholar
• Fisher ER, Rothstein R, Wholey MH. et al. Influence of nicotine on experimental atherosclerosis and its determinants. Arch Pathol 1973: 96(5): 298–304
   PubMedGoogle Scholar
• Fuchs R, Scheldt SS. Prevention of coronary atherosclerosis. Pt I. Cardiovasc Rev Rep 1983: 4(5): 671–95
   Google Scholar
• Oster G, Hose DM, Delea TE, et al. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA 1986: 256(10): 1315–8
   PubMed Web of Science ®Google Scholar
• Malcolm R, Currey HS, Mitchell MA, et al. Silver acetate gum as a deterrent to smoking. Chest 1986: 90(1): 107–11
   PubMed Web of Science ®Google Scholar
• Schmieder R, Lavie CJ, Messerli FH. The variability of arterial pressure: what is the clinical importance? Cardiovasc Rev Rep 1987: 8(2): 65–9
   Google Scholar
• The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis 1978: 31 (4): 201–306
   PubMedGoogle Scholar
• Schmieder RE, Messerli FH, Rnddel H. Risks for arterial hypertension. Cardiol Clin 1986: 4(1): 57–66
   PubMedGoogle Scholar
• Donahue RP, Abbott RD, Reed DM, et al. Alcohol and hemorrhagic stroke: the Honolulu Heart Program. JAMA 1986: 255(17): 2311–4
   PubMed Web of Science ®Google Scholar
• Klatsky AL, Friedman GD, Siegelaub AB, et al. Alcohol consumption and blood pressure. Kaiser-Permanente multiphasic health examination data. N Engl J Med 1977: 296(21): 1194–200
   PubMed Web of Science ®Google Scholar
• Grobbee DE, Hofman A. Does sodium restriction lower blood pressure? Br Med J (Clin Res) 1986: 293(6538): 27–9
   PubMed Web of Science ®Google Scholar
• Fisch IR, Freedman SH. Myatt AV. Oral contraceptives, pregnancy, and blood pressure. JAMA 1972: 222(12): 1507–10
   PubMed Web of Science ®Google Scholar
• Herbert P, Taylor JO, Hennekens CH. An overview of trials of pharmacologic therapy of mild hypertension. (Abstr) J Am Coll Cardiol 1986: 7(2): 164A
   Web of Science ®Google Scholar
• Connolly DC, Elveback LR, Oxman HA. Coronary heart disease in residents of Rochester, Minnesota, 1950–75. III. Effect of hypertension and its treatment on survival of patients with coronary artery disease. Mayo Clin Proc 1983: 58(4): 249–54
   PubMed Web of Science ®Google Scholar
• Grundy SM. Cholesterol and coronary heart disease: a new era. JAMA 1986: 256(20): 2849–58
   PubMed Web of Science ®Google Scholar
• Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986: 57(14)5–10G
   Web of Science ®Google Scholar
• Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981: 40(1): 1–52
   PubMed Web of Science ®Google Scholar
• Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J (Clin Res) 1986: 293(6542): 306–7
   PubMed Web of Science ®Google Scholar
• Brunzell JD, Sniderman AD, Albers JJ, et al. Apoproteins B and A-1 and coronary artery disease in humans. Arteriosclerosis 1984: 4(2): 79–83
   PubMedGoogle Scholar
• Campeau L, Enjalbert M. Lespérance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. N Engl J Med 1984: 311(21): 1329–32
   PubMed Web of Science ®Google Scholar
• Haskell WL, Camargo C Jr, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions: a controlled study. N Engl J Med 1984: 310(13): 805–10
   PubMed Web of Science ®Google Scholar
• Maciejko JJ, Holmes DR, Kottke BA, et al. Apolipoprotein A-I as a marker of angiographically assessed coronary artery disease. N Engl J Med 1983: 309(7): 385–9
   PubMed Web of Science ®Google Scholar
• Carlson LA, Bottiger LE. Risk factors for ischemic heart disease in men and women: results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985: 218(2): 207–11
   PubMedGoogle Scholar
• Sacks FM, Castelli WP, Donner A. et al. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med 1975: 292(22): 1148–51
   PubMed Web of Science ®Google Scholar
• Philips RL, Lemmon FR, Beeaon WL, et al. Coronary heart disease among Seventh-Day Adventlsts with differing habits: a preliminary report. Am J Clin Nutr 1978: 31: 5191–8
   Web of Science ®Google Scholar
• Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction In incidence of coronary heart disease. JAMA 1984: 251(3): 351–64
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Conference Summary. Lowering blood cholesterol to prevent heart disease. JAMA 1985: 253(14): 2080–6
   PubMed Web of Science ®Google Scholar
• Levy RI, Brensike JF, Epstein SE. et al. The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation 1984: 69(2): 325–37
   PubMed Web of Science ®Google Scholar
• Arntzenius AC, Kromhout D, Barth JD, et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985: 312(13): 805–11
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest 1986: 90(2): 275–9
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Amodeo C, Garavaglia GE, et al. Electrocardiographic left atrial abnormalities indicate diastolic ventricular dysfunction in obesity. (Abstr) J Am Coll Cardiol 1987: 9(2): 113A
   Web of Science ®Google Scholar
• Eichner ER. Coagulability and rheology: hematologic benefits from exercise, fish, and aspirin. Implications for athletes and nonathletes. Phys Sportsmed 1986: 14(10): 102–10
   PubMed Web of Science ®Google Scholar
• Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983: 67(5): 968–77
   PubMed Web of Science ®Google Scholar
• Kramsch DM, Aspen AJ, Abramowitz BM. et al. Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on an atherogenic diet. N Engl J Med 1981: 305(25): 1483–9
   PubMed Web of Science ®Google Scholar
• Moxley TR, Brakman P, Astrup T. Resting levels of fibrinolysis in blood In Inactive and exercising men. J Appl Physiol 1970: 28(5): 549–52
   PubMed Web of Science ®Google Scholar
• Ernst E. Changes In blood rheology produced by exercise. (Letter) JAMA 1985: 253(20): 2962–3
   PubMed Web of Science ®Google Scholar
• Paffenbarger RS Jr, Hyde RT. Exercise in the prevention of coronary heart disease. Prev Med 1984: 13(1): 3–22
   PubMed Web of Science ®Google Scholar
• Paffenbarger RS Jr. Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986: 314(10): 605–13
   PubMed Web of Science ®Google Scholar
• Ekelund LG, Karon JM. Gordon DJ, et al. Prognostic value of the exercise tolerance test (ETT) for coronary heart disease mortality in men: the Lipid Research Clinics (LRC) follow-up study. (Abstr) In: Proceedings of 24th Conference on Cardiovascular Disease Epidemiology. Tampa. Florida, Mar 8–9, 1984
   Google Scholar
• Rautaharju PM, Prineas RJ, Eifler WJ, et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol 1986: 8(1): 1–10
   PubMed Web of Science ®Google Scholar
• Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985: 312(19): 1205–9
   PubMed Web of Science ®Google Scholar
• Shekelle RB, Paul O, Shryock AM, et al. Fish consumption and mortality from coronary heart disease. (Letter) N Engl J Med 1985: 313(13): 820
   PubMedGoogle Scholar
• Norris PG, Jones CJ, Weston MJ. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Br Med J (Clin Res) 1986: 293(6539): 104–5
   PubMed Web of Science ®Google Scholar
• Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration cooperative study. N Engl J Med 1983: 309(7): 396–403
   PubMed Web of Science ®Google Scholar
• Cairns JA, Gent M. Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med 1985: 313(22): 1369–75
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Schmieder R, Genton E. Antiplatelet therapy for cardiovascular diseases. Cardiovasc Rev Rep 1987 (in press)
   Google Scholar
• Linos A, Worthington JW, O'Fallon W, et al. Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis: a long-term follow-up study. Mayo Clin Proc 1978: 53(9): 581–6
   PubMed Web of Science ®Google Scholar
• The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978: 299(2): 53–9
   PubMed Web of Science ®Google Scholar
• Bousser MG, Eschwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983: 14(1): 5–14
   PubMed Web of Science ®Google Scholar